Skip to main content

Table 4 Clinical characteristics of patients with MS and the HLA-DRB1*04:05 allele

From: Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study

 

Northern patients

(n = 92)

Southern patients

(n = 80)

p value

Number of males/females (ratio)

27/65 (1:2.4)

25/55 (1:2.2)

NS

Age (years)a

41 (34–49.5)

36 (28–49)

NS

Age at onset (years)a

27 (21–34)

25 (20–36.8)

NS

SPMS (%)

19/92 (20.7)

7/78 (9.0)

0.035

Disease duration (years)a

10 (6–17)

7.5 (4–14.8)

NS

EDSSa

2.0 (1.0–3.5)

2.0 (1.0–3.0)

NS

MSSSa

1.97 (0.56–5.63)

2.28 (1.04–4.97)

NS

ARRa

0.40 (0.25–0.71)

0.37 (0.17–0.71)

NS

Barkhof criteria (%)

69/92 (75.0 %)

44/78 (56.4 %)

0.0105

Positive OB and/or increased IgG index (%)

41/69 (59.4 %)

17/60 (28.3 %)

0.0004

  1. The Mann–Whitney U test was used to compare continuous variables, and the chi-square test was used to compare categorical variables
  2. ARR annualized relapse rate, EDSS Kurtzke’s Expanded Disability Status Scale, MSSS Multiple Sclerosis Severity Score, OB oligoclonal IgG bands, SPMS secondary progressive multiple sclerosis
  3. aMedian (interquartile range)